Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
Clinical trial NCT02583438 · UNKNOWN
Trial details
- NCT number
- NCT02583438
- Sponsor
- Beijing Chao Yang Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.